Skip to main content

Table 6 Observed vs. Predicted EQ-5D Utility by Symptom Group from QLQ-C30 Model

From: Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma

  Actual Predicted (95% CI) Difference
Symptom group    
  Asymptomatic 0.923 0.892 (0.816; 0.968) 0.031
  Mildly symptomatic 0.806 0.830 (0.780; 0.880) −0.024
  Moderately symptomatic 0.675 0.682 (0.617; 0.747) −0.007
  Severely symptomatic 0.501 0.476 (0.404; 0.548) 0.025